Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2007
08/08/2007EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN101014605A Tricyclic pyrazole derivatives as cannabinoid receptor modulators
08/08/2007CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase
08/08/2007CN101014580A Morpholine compound
08/08/2007CN101012233A Thienopyrrolizine derivative, its preparing method and pharmaceutical composition containing the same
08/07/2007US7253292 Synthesis of cyclopentadiene derivatives
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/02/2007WO2007066127A3 Thieno ( 3 , 2-c) pyridine compounds
08/02/2007WO2006073968A3 Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070176164 -Conjugated aromatic ring-containing compound and organic electroluminescent device
08/01/2007EP1813618A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran
08/01/2007EP1813616A2 Pyrazoloquinolines with immunomodulating activity
08/01/2007EP1813607A2 Tetraaza- or N2S2- complexants, and their use in radiodiagnostics or radiotherapy
08/01/2007EP1812446A1 Pharmaceutical compounds
08/01/2007EP1812445A1 Pharmaceutical compounds
08/01/2007EP1812444A1 Pharmaceutical compounds
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
08/01/2007CN1329034C Method for preventing/treating damage to sensory hair cells and cochlear neurons
07/2007
07/26/2007WO2007084560A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH
07/26/2007WO2007084557A2 Azaindoles useful as inhibitors of janus kinases
07/26/2007WO2007084391A2 Thiazole compounds as protein kinase b ( pkb) inhibitors
07/26/2007WO2007067781A3 9-membered heterobicyclic compounds as inhibitors of protein kinases
07/26/2007WO2007062167A9 Method of modulating stress-activated protein kinase system
07/26/2007WO2007053869A3 Novel 2,2-dithiosubstituted furanose derivatives, method for the production and use thereof
07/26/2007US20070173650 Chemical intermediate in manufacturing compounds having trithiaadamantane anchors
07/26/2007US20070173526 Compounds and methods for treating dyslipidemia
07/26/2007US20070172849 Detection of markers in nascent proteins
07/26/2007CA2637385A1 Compounds for the treatment of inflammatory disorders
07/26/2007CA2637245A1 Inhibitors of tnf.alpha., pde4 and b-raf, compositions thereof and methods of use therewith
07/25/2007EP1809635A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives
07/25/2007EP1809634A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives
07/25/2007EP1809619A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
07/25/2007EP1419772B1 Preventive agent/remedial agent for constipation predominant ibs
07/25/2007CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
07/24/2007US7247652 β-benzyloxyaspartate derivatives with amino group on benzene ring
07/19/2007WO2007081517A2 Anti-viral compounds
07/19/2007CA2633752A1 Anti-viral compounds
07/18/2007EP1807434A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
07/18/2007EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/18/2007CN1326859C Thienopyridine derivatives and their preparing process and use
07/18/2007CN101001862A Tricyclic compounds and their use as MGLUR1 antagonists
07/18/2007CN101001861A Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
07/18/2007CN100999525A Preparation process of clopidogre and its salt
07/17/2007US7244809 Semiconductors or charge transport materials in optical, electrooptical or electronic devices including field effect transistors, electroluminescent, photovoltaic and sensor devices
07/17/2007US7244727 Fused bicyclic nitrogen-containing heterocycles
07/17/2007US7244725 treatment of Alzheimer's disease and more specifically compounds that are capable of inhibiting beta-secretase
07/17/2007CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives
07/12/2007WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
07/12/2007WO2007077134A1 Method for preparing a mixed solvate of 0lanzapine
07/12/2007WO2007059257A8 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
07/12/2007WO2007056091A3 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
07/12/2007WO2007052300A3 Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
07/12/2007WO2007038209A3 Fused tetracyclic mglur1 antagonists as therapeutic agents
07/12/2007WO2007032023A3 A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
07/12/2007WO2007027780A3 Benzopyran and pyranopyridine derivatives as potassium channel openers
07/12/2007WO2006058723A8 New pyridothienopyrimidine derivatives
07/12/2007US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
07/12/2007US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders
07/12/2007US20070160871 Material for organic electroluminescent device and organic electroluminescent device
07/12/2007CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
07/11/2007EP1806347A1 Aromatic-ring-fused pyrimidine derivative
07/11/2007EP1805150A2 Heterocyclical chromophore architectures
07/11/2007EP1805144A1 Heterocyclical chromophore architectures
07/11/2007EP1355886B1 Fused heterocyclic compounds
07/11/2007EP1248784B1 Condensed azepines as vasopressin agonists
07/11/2007CN1997650A Chalcogen-containing fused-ring polycyclic organic material and process for producing the same
07/11/2007CN1997649A Inhibitors of histone deacetylase
07/11/2007CN1997648A Polymorphic forms of methyl(+)-(S)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-C]pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide
07/11/2007CN1997647A Clopidogrel salt and polymorphic forms thereof
07/11/2007CN1997366A Imidazole and thiazole derivatives as antiviral agents
07/11/2007CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/11/2007CN1325487C Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
07/10/2007US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
07/10/2007US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives
07/05/2007WO2007076085A2 Fused pyrimidones and thiopyrimidones, and uses thereof
07/05/2007WO2007074995A1 Process for the preparation of s-(+)-clopidogrel by optical resolution
07/05/2007WO2007058392A9 Heterocyclic compound and medicinal application thereof
07/05/2007WO2006056697A8 Substituted thieno[2,3-c]pyrazoles, method for the preparation thereof, compositions containing them and use thereof
07/05/2007US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay
07/05/2007US20070155777 Antiinflammation agents
07/05/2007US20070155776 Thienopyridine and furopyridine kinase inhibitors
07/05/2007US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
07/05/2007US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
07/05/2007US20070155719 Platelet ADP receptor inhibitors
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007CA2635255A1 Process for the preparation of s-(+)-clopidogrel by optical resolution
07/05/2007CA2634437A1 4,7-dihydrothieno¬2,3-b|pyridine compounds and pharmaceutical compositions
07/05/2007CA2634061A1 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
07/04/2007EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring
07/04/2007EP1802634A2 Thiophens and their use as anti-tumor agents
07/04/2007EP1802633A1 Benzothieno[2,3-d]pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases
07/04/2007EP1802632A1 Thieno-pyrimidine compounds having fungicidal activity
07/04/2007EP1802631A2 Thienopyridinone compounds and methods of treatment
07/04/2007EP1260512B1 Novel cyclic amide derivatives
07/04/2007CN1993360A Condensed pyridines as kinase inhibitors
07/04/2007CN1993129A Thienopyrimidines and thiazolopyrimidines for use in medicine
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 214